USC.edu
Are You a Patient?

John C. Lipham, MD

Professor of Clinical Surgery

Division Chief of Upper GI and General Surgery

Director, Foregut Cancer Program

Chief of USC Affiliated Academic Programs at Hoag Memorial Hospital

Image of John C. Lipham, MD
Is this your profile? Click to edit
Request an Appointment
Phone +1 714 288 8098
Email [email protected]
CTSI Profile

Overview

John C. Lipham, M.D. is Chief of the Division of Upper GI and General Surgery and Associate Professor of Surgery at the Keck School of Medicine of USC. Dr. Lipham also served as the Foregut Cancer Program Director and Chief of USC Affiliated Academic Programs at Hoag. He was instrumental in establishing the Hoag-USC Surgical Center for Digestive Diseases. He focuses on benign and malignant diseases of the esophagus and stomach. His clinical interests include the diagnosis and treatment of GERD, hiatal hernias, Barrett’s esophagus, esophageal motility disorders, achalasia, malignant diseases of the esophagus and stomach, and gastroparesis. His current research interests include developing minimally invasive methods of diagnosing and treating gastroesophageal reflux disease, Barrett’s, esophageal cancer and gastric cancer.

Publications

  • Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn. Dis Esophagus. 2020 Apr 15; 33(4).. View in PubMed
  • Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020 Apr; 30(2):325-342.. View in PubMed
  • Management of lateral abdominal hernias. Hernia. 2020 04; 24(2):353-358.. View in PubMed
  • Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointest Endosc. 2020 07; 92(1):78-87.e2.. View in PubMed
  • Volumetric laser endomicroscopy and its application to Barrett’s esophagus: results from a 1,000 patient registry. Dis Esophagus. 2019 Nov 13; 32(9).. View in PubMed
  • A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective. Surg Endosc. 2020 04; 34(4):1561-1572.. View in PubMed
  • Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized Trial. Clin Gastroenterol Hepatol. 2020 07; 18(8):1736-1743.e2.. View in PubMed
  • Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation: One Year Results From a Post Approval Study. Ann Surg. 2019 08; 270(2):302-308.. View in PubMed
  • Clinical Significance of Esophageal Outflow Resistance Imposed by a Nissen Fundoplication. J Am Coll Surg. 2019 08; 229(2):210-216.. View in PubMed
  • Extraluminal Approaches to Gastroesophageal Reflux Disease. Thorac Surg Clin. 2018 Nov; 28(4):521-526.. View in PubMed

Similar People